Eli Lilly $LLY said its experimental drug retatrutide helped patients with Type 2 diabetes shed up to 16.8% of their body weight over 40 weeks in a Phase 3 trial, outpacing all diabetes drugs now available.
Report of a joint FAO/WHO/UNV Expert Consultation, Technical Report Series 74
A glutathione S-transferase confers herbicide tolerance in rice
Market research suggests that 1 in 4 consumers globally have altered their diet to lose weight in the past year
Astaxanthin might help repair or prevent skin damage, though
Commercial insurance, Medicare, Medicaid, and pharmacy benefit plans generally evaluate coverage based on approved indications, product labeling, plan formularies, prior-authorization criteria, and medical-necessity rules